‹ Knowledge base
Browse the corpus
Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.
- 10-year outcome of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction - A DANAMI-3 PRIMULTI substudy1 passage
- A literature review to evaluate the economic value of ranolazine for the symptomatic treatment of chronic angina pectoris1 passage
- A new approach to the clinical subclassification of heart failure with preserved ejection fraction1 passage
- Acupuncture for heart failure: A systematic review of clinical studies1 passage
- Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: A population-based study1 passage
- Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial1 passage
- Associations of systemic oxidative stress with functional outcomes after ST-segment elevation myocardial infarction1 passage
- Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes1 passage
- Bare metal versus drug eluting stents for ST-segment elevation myocardial infarction in the TOTAL trial1 passage
- Beneficial effects of exercise training on physical performance in patients with vasospastic angina1 passage
- Benefits and limitations of implementing Chronic Care Model (CCM) in primary care programs: A systematic review1 passage
- Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial1 passage
- Colchicine for secondary prevention in patients with acute coronary syndrome: A systematic review and meta-analysis1 passage
- Comparison of Watchman device with new oral anti-coagulants in patients with atrial fibrillation: A network meta-analysis1 passage
- Continuous and minimally-interrupted direct oral anticoagulant are both safe compared with vitamin K antagonist for atrial fibrillation ablation: An updated meta-analysis1 passage
- Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis1 passage
- Deep learning to detect significant coronary artery disease from plain chest radiographs AI4CAD1 passage
- Direct oral anticoagulants or vitamin K antagonists after TAVR: A systematic review and meta-analysis1 passage
- Dose-effect relationship of perindopril 10, 14 and 20mg assessed by urine and plasma AcSDKP levels in mildly sodium-depleted healthy volunteers1 passage
- Early changes of left ventricular filling pattern after reperfused ST-elevation myocardial infarction and doxycycline therapy: Insights from the TIPTOP trial1 passage
- Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease1 passage
- Effect of percutaneous coronary intervention for chronic total occlusion on diastolic atrioventricular coupling in ST-elevation myocardial infarction patients1 passage
- Effectiveness of CHA(2)DS(2)-VASc based decision support on stroke prevention in atrial fibrillation: A cluster randomised trial in general practice1 passage
- Effects of remote ischemic preconditioning in patients with concentric myocardial hypertrophy: A randomized, controlled trial with molecular insights1 passage
- FFR-guided multivessel stenting reduces urgent revascularization compared with infarct-related artery only stenting in ST-elevation myocardial infarction: A meta-analysis of randomized controlled trials1 passage
- Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients1 passage
- Hyperuricemia and contrast-induced acute kidney injury: A systematic review and meta-analysis1 passage
- Immediate versus staged complete revascularization in patients presenting with multivessel disease and ST- or non-ST-segment elevation acute coronary syndrome1 passage
- Impact of chronic total occlusion in a non-infarct-related coronary artery on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in ST-elevation myocardial infarction1 passage
- Impact of direct stenting on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in ST-elevation myocardial infarction1 passage
- Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis1 passage
- Inflammatory cell response following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention and its impact on cardiovascular outcomes: A systematic review and meta-analysis1 passage
- Intensive atorvastatin improves endothelial function and decreases ADP-induced platelet aggregation in patients with STEMI undergoing primary PCI: A single-center randomized controlled trial1 passage
- Intravenous beta-blockers in ST-segment elevation myocardial infarction: A systematic review and meta-analysis1 passage
- Left ventricular thrombi after STEMI in the primary PCI era: A systematic review and meta-analysis1 passage
- Low diastolic blood pressure and adverse outcomes in heart failure with preserved ejection fraction1 passage
- Myeloperoxidase, carnitine, and derivatives of reactive oxidative metabolites in heart failure with preserved versus reduced ejection fraction: A meta-analysis1 passage
- Myocardial contraction fraction predicts outcomes in patients enrolled in the TOPCAT trial1 passage
- Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF1 passage
- Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: A systematic review and network meta-analysis1 passage
- Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis1 passage
- Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment1 passage
- Outcome trial data on sodium glucose cotransporter-2 inhibitors: Putting clinical benefits and risks in perspective1 passage
- Prasugrel as opposed to clopidogrel improves endothelial nitric oxide bioavailability and reduces platelet-leukocyte interaction in patients with unstable angina pectoris: A randomized controlled trial1 passage
- Pre-hospital ticagrelor in ST-segment elevation myocardial infarction in the French ATLANTIC population1 passage
- Pre-perfusion coronary wedge pressure and microvascular obstruction in anterior ST elevation myocardial infarction (STEMI): An analysis from the EUROICE study1 passage
- Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial1 passage
- Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure1 passage
- Prognostic impact of persistent microvascular obstruction on cardiac magnetic resonance after STEMI: A systematic review and meta-analysis1 passage
- Radial access in patients with acute coronary syndrome without persistent ST-segment elevation: Systematic review, collaborative meta-analysis, and meta-regression1 passage
- RenalGuard system and conventional hydration for preventing contrast-associated acute kidney injury in patients undergoing cardiac interventional procedures: A systematic review and meta-analysis1 passage
- Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis1 passage
- Rise of first follow-up sodium in patients hospitalized with acute heart failure is associated with better outcomes1 passage
- Safety and efficacy of platelet-derived mitochondrial transplantation in ischaemic heart disease1 passage
- Safety outcomes of SGLT2i in the heart failure trials: A systematic review and Meta-analysis1 passage
- Strategy of dual antiplatelet therapy for patients with ST-elevation myocardial infarction and non-ST-elevation acute coronary syndromes: A systematic review and network meta-analysis1 passage
- Systematic review and meta-analysis of diagnostic test accuracy of ST-segment elevation for acute coronary occlusion1 passage
- Therapeutic efficacy of PCSK9 monoclonal antibodies in statin-nonresponsive patients with hypercholesterolemia and dyslipidemia: A systematic review and meta-analysis1 passage
- Ultrafiltration for acute decompensated cardiac failure: A systematic review and meta-analysis1 passage
- Validation of contemporary electrocardiographic indices of area at risk and infarct size in acute ST elevation myocardial infarction (STEMI)1 passage